Literature DB >> 10943637

Interferon gamma-1b therapy for cryptogenic fibrosing alveolitis.

J Britton1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10943637      PMCID: PMC1765942          DOI: 10.1136/thorax.55.suppl_1.s37

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  13 in total

1.  Interferon gamma-1b for the treatment of idiopathic pulmonary fibrosis.

Authors:  R M Du Bois
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

Review 2.  NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future.

Authors:  R J Mason; M I Schwarz; G W Hunninghake; R A Musson
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

3.  British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society.

Authors:  I D Johnston; R J Prescott; J C Chalmers; R M Rudd
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

4.  Five-hundred life-saving interventions and their cost-effectiveness.

Authors:  T O Tengs; M E Adams; J S Pliskin; D G Safran; J E Siegel; M C Weinstein; J D Graham
Journal:  Risk Anal       Date:  1995-06       Impact factor: 4.000

5.  The epidemiology of interstitial lung diseases.

Authors:  D B Coultas; R E Zumwalt; W C Black; R E Sobonya
Journal:  Am J Respir Crit Care Med       Date:  1994-10       Impact factor: 21.405

6.  Cryptogenic fibrosing alveolitis: clinical features and their influence on survival.

Authors:  M Turner-Warwick; B Burrows; A Johnson
Journal:  Thorax       Date:  1980-03       Impact factor: 9.139

7.  What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust.

Authors:  J Scott; I Johnston; J Britton
Journal:  BMJ       Date:  1990-11-03

8.  A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis.

Authors:  R Ziesche; E Hofbauer; K Wittmann; V Petkov; L H Block
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

9.  Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.

Authors:  M A Johnson; S Kwan; N J Snell; A J Nunn; J H Darbyshire; M Turner-Warwick
Journal:  Thorax       Date:  1989-04       Impact factor: 9.139

10.  Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial.

Authors:  G Raghu; W J Depaso; K Cain; S P Hammar; C E Wetzel; D F Dreis; J Hutchinson; N E Pardee; R H Winterbauer
Journal:  Am Rev Respir Dis       Date:  1991-08
View more
  1 in total

1.  Transient Transfection of the Respiratory Epithelium with Gamma Interferon for Host-Directed Therapy in Pulmonary Tuberculosis.

Authors:  Reena Bharti; Ashish Srivastava; Trisha Roy; Khushboo Verma; D V Siva Reddy; Hasham Shafi; Sonia Verma; Sunil K Raman; Amit K Singh; Jyotsna Singh; Lipika Ray; Amit Misra
Journal:  Mol Ther Nucleic Acids       Date:  2020-10-22       Impact factor: 8.886

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.